Rare Diseases: Bridging the Gap between Drug Manufacturers and Payers
High prices for drugs for rare diseases have introduced uncertainties from payers around whether a medication’s value justifies its price.
High prices for drugs for rare diseases have introduced uncertainties from payers around whether a medication’s value justifies its price.